In this study, we showed that zoledronate attenuated blood flow recovery and reduced ischemia-induced neovascularization by downregulating EPC mobilization and resulted in a reduction in tube formation by attenuating the activity of MMP-9, eNOS, and Akt. This evidence concerns the gene AKT1 and ischemia.